Home
About
Overview
Sharing Data
ORCID
Help
History (161)
Zimmermann, Laura
Apamin
Food Service, Hospital
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer.
NSAID exposure and risk of Alzheimer disease: is timing everything?
See All 161 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
NSAID exposure and risk of Alzheimer disease: is timing everything?
NSAID exposure and risk of Alzheimer disease: is timing everything? Neurology. 2009 Jun 02; 72(22):1884-5.
View in:
PubMed
subject areas
Age Distribution
Age Factors
Aged
Aging
Alzheimer Disease
Anti-Inflammatory Agents, Non-Steroidal
Body Mass Index
Brain
Causality
Cohort Studies
Comorbidity
Data Interpretation, Statistical
Disease Progression
Drug-Related Side Effects and Adverse Reactions
Humans
Obesity
Risk Factors
authors with profiles
David A Bennett